Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017 Document date: 2017_11_7
ID: roslkxeq_363
Snippet: Disclosures: No disclosures to report. The aim of this study was to i) determine whether there is evidence of CPPV1 infection in feral carnivores and viral traffic between these and companion animals (ii) model in silico the susceptibility of the Tasmanian devil to CPPV1. Reticuloendothelial tissue samples were sourced from deceased feral carnivores for PCR amplification and sequencing of a 529 bp region of the CPPV1 VP2 gene. Phylogenetic analys.....
Document: Disclosures: No disclosures to report. The aim of this study was to i) determine whether there is evidence of CPPV1 infection in feral carnivores and viral traffic between these and companion animals (ii) model in silico the susceptibility of the Tasmanian devil to CPPV1. Reticuloendothelial tissue samples were sourced from deceased feral carnivores for PCR amplification and sequencing of a 529 bp region of the CPPV1 VP2 gene. Phylogenetic analysis of partial VP2 gene sequences was performed using the maximum likelihood method. Tasmanian devil susceptibility to infection was investigated by comparison of their transferrin receptor type 2 (TfR) sequence at binding sites for CPPV1 to susceptible carnivores, and phylogenetic analysis of TfR protein.
Search related documents:
Co phrase search for related documents- partial VP2 gene sequence phylogenetic analysis and phylogenetic analysis: 1
- partial VP2 gene sequence phylogenetic analysis and study aim: 1
- PCR amplification and phylogenetic analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- PCR amplification and sequencing PCR amplification: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- PCR amplification and study aim: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- PCR amplification and tissue sample: 1, 2
- phylogenetic analysis and sequencing PCR amplification: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- phylogenetic analysis and study aim: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56
- phylogenetic analysis and tasmanian devil: 1
- phylogenetic analysis and tissue sample: 1
- phylogenetic analysis and VP2 gene sequence: 1, 2, 3, 4
- sequencing PCR amplification and study aim: 1, 2, 3
- study aim and tissue sample: 1, 2, 3
- study aim and transferrin receptor: 1, 2, 3
- study aim and VP2 gene sequence: 1
- tasmanian devil and TfR protein: 1
- TfR protein and transferrin receptor: 1
- transferrin receptor and viral traffic: 1
Co phrase search for related documents, hyperlinks ordered by date